KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Exchange Rate Effect (2016 - 2025)

Historic Exchange Rate Effect for Eli Lilly (LLY) over the last 17 years, with Q4 2025 value amounting to -$67.1 million.

  • Eli Lilly's Exchange Rate Effect rose 8435.17% to -$67.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $372.0 million, marking a year-over-year increase of 22525.25%. This contributed to the annual value of $372.0 million for FY2025, which is 22525.25% up from last year.
  • Latest data reveals that Eli Lilly reported Exchange Rate Effect of -$67.1 million as of Q4 2025, which was up 8435.17% from $31.7 million recorded in Q3 2025.
  • Eli Lilly's 5-year Exchange Rate Effect high stood at $275.5 million for Q2 2025, and its period low was -$428.8 million during Q4 2024.
  • Over the past 5 years, Eli Lilly's median Exchange Rate Effect value was $7.0 million (recorded in 2021), while the average stood at -$6.5 million.
  • In the last 5 years, Eli Lilly's Exchange Rate Effect plummeted by 90697.67% in 2022 and then soared by 418113.21% in 2024.
  • Eli Lilly's Exchange Rate Effect (Quarter) stood at -$220.7 million in 2021, then soared by 41.91% to -$128.2 million in 2022, then skyrocketed by 201.17% to $129.7 million in 2023, then tumbled by 430.61% to -$428.8 million in 2024, then surged by 84.35% to -$67.1 million in 2025.
  • Its last three reported values are -$67.1 million in Q4 2025, $31.7 million for Q3 2025, and $275.5 million during Q2 2025.